BioSpace News Archive

Thermo Scientific HAAKE MARS iQ Rheometer series provides more analytical capabilities for QC and reliable, user-independent results

Deal will accelerate drug development for Duchenne muscular dystrophy, a rare disease that affects 300,000 boys and young men worldwide

Boston Biomedical, Inc. announced the continuation of the CanStem303C study evaluating the safety and efficacy of investigational agent napabucasin when given in combination with FOLFIRI with or without bevacizumab in patients with advanced colorectal cancer.

The Financial Services Cares Gala (FSCG) will celebrate its 14th year on Thursday, June 13, 2019, at the New York Hilton Midtown

Meru Health and Littleton-based business psychology firm MINES & Associates (MINES) today announced that they will work together to improve access to mental health care for over 10,000 of MINES’ managed behavioral health care members.

The world’s largest annual event for the biomedical sector, BIO International Convention (BIO 2019), is being held in Philadelphia, Pennsylvania from June 3rd to 6th this year

Endologix® Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been reinstated by GMED, the EU Notified Body for the Nellix System.

On May 31, NuLeaf Naturals representative Crystal Guess was one of 140 individuals to testify in a groundbreaking public meeting called by the Food and Drug Administration (FDA)

bluebird bio, Inc. announced that the company will host a live webcast to review new data presented at the European Hematology Association Annual Meeting, and to discuss the approval of ZYNTEGLO® on Friday, June 14 at 8:00 a.m. ET.

First anti-IL5 biologic to give healthcare professionals choice of how and where their patients receive treatment